Journal
Open Forum Infectious Diseases
Publication Date
6-1-2020
Volume
7
Issue
6
First Page
ofaa157
Document Type
Open Access Publication
DOI
10.1093/ofid/ofaa157
Rights and Permissions
Erik R Dubberke, Dale N Gerding, Ciarán P Kelly, Kevin W Garey, Galia Rahav, Audrey Mosley, Robert Tipping, Mary Beth Dorr, Efficacy of Bezlotoxumab in Participants Receiving Metronidazole, Vancomycin, or Fidaxomicin for Treatment of Clostridioides (Clostridium) difficile Infection, Open Forum Infectious Diseases, Volume 7, Issue 6, June 2020, ofaa157, https://doi.org/10.1093/ofid/ofaa157. © The Author(s) 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com DOI: 10.1093/ofid/ofaa157. https://academic.oup.com/ofid/article/7/6/ofaa157/5850187.
Recommended Citation
Dubberke, Erik R.; Gerding, Dale N.; Kelly, Ciarán P.; Garey, Kevin W.; Rahav, Galia; Mosley, Audrey; Tipping, Robert; and Dorr, Mary Beth, "Efficacy of bezlotoxumab in participants receiving metronidazole, vancomycin, or fidaxomicin for treatment of Clostridioides (Clostridium) difficile infection." Open Forum Infectious Diseases. 7, 6. ofaa157 (2020).
https://digitalcommons.wustl.edu/open_access_pubs/9390
